Skip to main content

Medication adherence

09-23-2022 | EASD 2022 | Conference coverage | News

​​​​​​​Better diabetes self-care during adolescence could improve glycemic control trajectory

Among adolescents with type 1 diabetes, those with better self-care are more likely to have favorable glycated hemoglobin trajectories into early adulthood, study findings suggest.

09-28-2021 | EASD 2021 | Conference coverage | News

Real-world GLP-1 receptor agonist persistence improved with weekly formulation

The real-world STAY study suggests that people take GLP-1 receptor agonists more consistently and for longer if given a weekly rather than daily formulation.

12-21-2020 | Dulaglutide | News

Longer treatment persistence with dulaglutide vs other GLP-1 receptor agonists in type 2 diabetes

Dulaglutide is associated with better treatment persistence and lower rates of treatment modification versus other glucagon-like peptide‑1 receptor agonists in people with type 2 diabetes, suggests a study of Swedish health registries.

02-20-2020 | Mobile technology | News

Mobile access to online self-management tools may improve diabetes care

People with diabetes who access an online self-management portal through mobile devices have better medication adherence and glycemic control than those with computer-only or no access to the portal, researchers report.

10-11-2019 | Medication adherence | News

Removing cost barriers not complete answer for medication adherence

Offering free medications to patients who struggle to afford them improves adherence, but with mixed effects on surrogate disease outcomes, report the CLEAN Meds researchers.

09-13-2019 | Medication adherence | News

Prescription records best clinical indicator of future diabetes medication adherence

Adherence to first-line diabetes medication, ascertained from prescription records, is the only routine clinical variable that is a strong indicator of people’s adherence to second-line treatment, say researchers.

03-15-2019 | Medication adherence | News

Targeted insulin-adherence intervention may improve glycemic control

Targeting specific populations of individuals with type 2 diabetes for intensive interventions to optimize their insulin use may result in better glycemic control than an untargeted approach, findings from the TARGIT-Diabetes trial suggest.

10-05-2018 | Insulin | EASD 2018 | News

‘Alarming’ rates of insulin discontinuation in developing countries

A substantial proportion of diabetes patients living in resource-poor settings intermittently discontinue insulin for a variety of different reasons, IDMPS study results suggest.